Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 335

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer

Open access
Kreimer, Aimée R., Johansson, Mattias, Waterboer, Tim, Kaaks, Rudolf, Chang-Claude, Jenny, Drogen, Dagmar, Tjønneland, Anne, Overvad, Kim, Quirós, J. Ramón, González, Carlos A., Sánchez, Maria José, Larrañaga, Nerea, Navarro, Carmen, Barricarte, Aurelio, Travis, Ruth C., Khaw, Kay-Tee, Wareham, Nick, Trichopoulou, Antonia, Lagiou, Pagona, Trichopoulos, Dimitrios, Peeters, Petra H.M., Panico, Salvatore, Masala, Giovanna, Grioni, Sara, Tumino, Rosario, Vineis, Paolo, Bueno-de-Mesquita, H. Bas, Laurell, Göran, Hallmans, Göran, Manjer, Jonas, Ekström, Johanna, Skeie, Guri, Lund, Eiliv, Weiderpass, Elisabete, Ferrari, Pietro, Byrnes, Graham, Romieu, Isabelle, Riboli, Elio, Hildesheim, Allan, Boeing, Heiner, Pawlita, Michael, Brennan, Paul · 2013 · Journal of Clinical Oncology

Abstract

Purpose: Human papillomavirus type 16 (HPV16) infection is causing an increasing number of oropharyngeal cancers in the United States and Europe. The aim of our study was to investigate whether HPV antibodies are associated with head and neck cancer risk when measured in prediagnostic sera. Methods: We identified 638 participants with incident head and neck cancers (patients; 180 oral cancers, 135 oropharynx cancers, and 247 hypopharynx/larynx cancers) and 300 patients with esophageal cancers as well as 1,599 comparable controls from within the European Prospective Investigation Into Cancer and Nutrition cohort. Prediagnostic plasma samples from patients (collected, on average, 6 years before diagnosis) and control participants were analyzed for antibodies against multiple proteins of HPV16 as well as HPV6, HPV11, HPV18, HPV31, HPV33, HPV45, and HPV52. Odds ratios (ORs) of cancer and 95% CIs were calculated, adjusting for potential confounders. All-cause mortality was evaluated among patients using Cox proportional hazards regression. Results: HPV16 E6 seropositivity was present in prediagnostic samples for 34.8% of patients with oropharyngeal cancer and 0.6% of controls (OR, 274; 95% CI, 110 to 681) but was not associated with other cancer sites. The increased risk of oropharyngeal cancer among HPV16 E6 seropositive participants was independent of time between blood collection and diagnosis and was observed more than 10 years before diagnosis. The all-cause mortality ratio among patients with oropharyngeal cancer was 0.30 (95% CI, 0.13 to 0.67), for patients who were HPV16 E6 seropositive compared with seronegative. Conclusion: HPV16 E6 seropositivity was present more than 10 years before diagnosis of oropharyngeal cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2012.47.2738

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 335

Metadata

Authors
Kreimer, A. R., Johansson, M., Waterboer, T., Kaaks, R., Chang-Claude, J., Drogen, D., Tjønneland, A., Overvad, K., Quirós, J. R., González, C. A., Sánchez, M. J., Larrañaga, N., Navarro, C., Barricarte, A., Travis, R. C., Khaw, K.-T., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H. M., Panico, S., Masala, G., Grioni, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, H. B., Laurell, G., Hallmans, G., Manjer, J., Ekström, J., Skeie, G., Lund, E., Weiderpass, E., Ferrari, P., Byrnes, G., Romieu, I., Riboli, E., Hildesheim, A., Boeing, H., Pawlita, M., & Brennan, P.
Venue
Journal of Clinical Oncology
Published
2013-07-20
Volume
31
Issue
21
Pages
2708-2715
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2148344434
Cited by
335
References
21
FWCI
31.94
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer. https://app.cochat.ai/papers/10.1200/jco.2012.47.2738
The paper
Kreimer, A. R., Johansson, M., Waterboer, T., Kaaks, R., Chang-Claude, J., Drogen, D., Tjønneland, A., Overvad, K., Quirós, J. R., González, C. A., Sánchez, M. J., Larrañaga, N., Navarro, C., Barricarte, A., Travis, R. C., Khaw, K.-T., Wareham, N., Trichopoulou, A., Lagiou, P., . . . Brennan, P. (2013). Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2012.47.2738

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.